What is Artiva Biotherapeutics, Inc.'s operating margin?

Artiva Biotherapeutics, Inc. (ARTV) reported operating margin of -83.9% in Q1 2024.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Artiva Biotherapeutics, Inc. ARTV Operating margin

Operating margin at other companies

Gilead SciencesGILD

34.9%+6.3pp

Allogene TherapeuticsALLO

-1,241,813.6%-2,018,140pp

ImmunityBio, Inc.IBRX

-185.4%-83.3pp

Nektar TherapeuticsNKTR

-242%—

Avalo TherapeuticsAVTX

-15,536.1%-17,275pp

Iovance Biotherapeutics, Inc.IOVA

-127.2%-31.0pp

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Calculated from Artiva Biotherapeutics, Inc.’s reported figures.

operating income/total revenue=-83.9%

Based on trailing twelve months.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2025, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s operating margin?: Artiva Biotherapeutics, Inc. (ARTV) reported operating margin of -83.9% in Q1 2024.
What does operating margin mean?: Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.